Your browser doesn't support javascript.
loading
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo).
Halmos, Balazs; Tan, Eng-Huat; Soo, Ross A; Cadranel, Jacques; Lee, Min Ki; Foucher, Pascal; Hsia, Te-Chun; Hochmair, Maximilian; Griesinger, Frank; Hida, Toyoaki; Kim, Edward; Melosky, Barbara; Märten, Angela; Carcereny, Enric.
Afiliación
  • Halmos B; Department of Oncology, Montefiore/Albert Einstein Cancer Center, 2nd floor, 1695 Eastchester Rd, Bronx, NY, 10461, USA. Electronic address: bahalmos@montefiore.org.
  • Tan EH; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. Electronic address: dmoteh@nccs.com.sg.
  • Soo RA; Department of Haematology-Oncology, National University Hospital, Singapore (NCIS), Levels 8-10 @ NUH Medical Centre (NUHMC), 1 Kent Ridge Road, Singapore. Electronic address: ross_soo@nuhs.edu.sg.
  • Cadranel J; Chest Department Hôpital Tenon and Sorbonne Université Paris VI, Service de Pneumologie, Hôpital Tenon, 4 rue de la Chine, Paris, 75970, France. Electronic address: jacques.cadranel@tnn.aphp.fr.
  • Lee MK; Pusan National University Hospital, Pusan National University College of Medicine, Pusan, South Korea. Electronic address: leemk@pusan.ac.kr.
  • Foucher P; Fédération d'Oncologie Thoracique, CHU Dijon-Bourgogne, Hôpital du Bocage, Centre Hospitalier Universitaire, 14, rue Gaffarel, 21079, Dijon Cedex, France. Electronic address: pascal.foucher@chu-dijon.fr.
  • Hsia TC; Department of Internal Medicine, China Medical University Hospital, Division of Pulmonary and Critical Care Medicine, Taichung, Taiwan. Electronic address: derrick.hsia@msa.hinet.net.
  • Hochmair M; Department of Respiratory and Critical Care Medicine, and Ludwig Boltzmann Institute of COPD and Respiratory Epidemiology, Otto-Wagner-Spital, Sanatoriumstrasse, 2, 1140 Vienna, Austria. Electronic address: maximilian.Hochmair@wienkav.at.
  • Griesinger F; Department of Hematology and Oncology, Pius-Hospital, University Department Internal Medicine-Oncology, University of Oldenburg, Oldenburg, Germany. Electronic address: Frank.Griesinger@Pius-Hospital.de.
  • Hida T; Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan. Electronic address: 107974@aichi-cc.jp.
  • Kim E; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Electronic address: Edward.kim@carolinashealthcare.org.
  • Melosky B; Department of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, BCCA, 600 W 10th Ave, Vancouver, Canada. Electronic address: bmelosky@bccancer.bc.ca.
  • Märten A; Boehringer Ingelheim GmbH & Co. KG, Binger Straße 173, Ingelheim am Rhein, 55216, Germany. Electronic address: angela.maerten@boehringer-ingelheim.com.
  • Carcereny E; Department of Medical Oncology, Catalan Institute of Oncology Badalona, Hospital Germans Trias i Pujol, Badalona, Spain. Electronic address: ecarcereny@iconcologia.net.
Lung Cancer ; 127: 103-111, 2019 01.
Article en En | MEDLINE | ID: mdl-30642537
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Afatinib Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Afatinib Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Irlanda